Tag Archive for: BioNTech-Pfizer

EU officials on Tuesday recommended that the two Omicron-tailored vaccines recently endorsed by the European Medicines Agency (EMA) be first deployed in high-risk individuals.

The European Medicines Agency (EMA) will hold an extraordinary meeting on Sept. 1 to discuss applications from Moderna and Pfizer for vaccine boosters modified to target the Omicron variant, the regulator said on Tuesday.

Adapted versions of established mRNA COVID-19 vaccines that address two variants in one shot will soon offer people better protection than vaccines that are now available, a European health official said on Wednesday.